You have 9 free searches left this month | for more free features.

GCA

Showing 1 - 25 of 121

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Giant Cell Arteritis, Polymyalgia Rheumatica Trial (Secukinumab)

Not yet recruiting
  • Giant Cell Arteritis
  • Polymyalgia Rheumatica
  • (no location specified)
Nov 8, 2023

Spatial Resolution of Several Contrast-enhanced 3D T1-WI

Not yet recruiting
  • Giant Cell Arteritis
  • 3D T1 MRI sequences injected with fat saturation and black blood
  • (no location specified)
May 9, 2023

Ultra-short Glucocorticosteroids and Tocilizumab Therapy in GCA

Active, not recruiting
  • GCA
  • +3 more
  • Tocilizumab 162Mg/0.9Ml Autoinjector
  • Reggio Emilia, Emilia Romagna, Italy
    Ausl-Irccs - S.C. Di Reumatologia
May 26, 2022

Giant Cell Arteritis, Polymyalgia Rheumatica Trial

Not yet recruiting
  • Giant Cell Arteritis
  • Polymyalgia Rheumatica
    • (no location specified)
    Jun 28, 2023

    Giant Cell Arteritis Trial in Boston (Tocilizumab, Prednisone)

    Recruiting
    • Giant Cell Arteritis
    • Boston, Massachusetts
      Massachusetts General Hospital
    Jul 23, 2021

    Newly-diagnosed Polymyalgia Rheumatica and Giant Cell Arteritis

    Recruiting
    • Polymyalgia Rheumatica (PMR)
    • Giant Cell Arteritis (GCA)
    • Data collection for cellular analyses (Immune subset composition, GCR expression, in vitro steroid responsiveness)
    • +3 more
    • Basel, Switzerland
      Department of Rheumatology University Hospital Basel
    Aug 2, 2022

    Giant Cell Arteritis Trial (Secukinumab 300 mg, s.c., Placebo to match Secukinumab, s.c.)

    Recruiting
    • Giant Cell Arteritis
    • Secukinumab 300 mg, s.c.
    • Placebo to match Secukinumab, s.c.
    • Berlin, Germany
    • +2 more
    Oct 12, 2022

    Arteritis, Giant Cell Trial in Rochester (Baricitinib)

    Completed
    • Arteritis, Giant Cell
    • Rochester, Minnesota
      Mayo Clinic
    Apr 7, 2022

    Horton Disease Trial in Dijon (blood samples)

    Recruiting
    • Horton Disease
    • blood samples
    • Dijon, France
      CHU Dijon Bourgogne
    Sep 28, 2021

    Giant Cell Arteritis Trial in Basel, Bern (Tocilizumab)

    Completed
    • Giant Cell Arteritis
    • Basel, Switzerland
    • +1 more
    Nov 4, 2021

    Giant Cell Arteritis (GCA) Trial in Worldwide (Secukinumab 300 mg, Placebo)

    Recruiting
    • Giant Cell Arteritis (GCA)
    • Secukinumab 300 mg
    • +2 more
    • Fontana, California
    • +83 more
    Nov 10, 2022

    Giant Cell Arteritis, Optic Ischaemic Neuropathy Trial in France (tocilizumab and IV steroids combination, IV steroids

    Recruiting
    • Giant Cell Arteritis
    • Optic Ischaemic Neuropathy
    • tocilizumab and IV steroids combination
    • IV steroids combination alone
    • Caen, France
    • +9 more
    Mar 3, 2022

    Optic Nerve Sheath Ultrasound in Giant Cell Arteritis

    Not yet recruiting
    • Giant Cell Arteritis
    • +2 more
    • Optic nerve ultrasound
    • Joliette, Quebec, Canada
    • +3 more
    Feb 18, 2023

    Vessel Wall Enhancement in Giant Cell Arteritis

    Recruiting
    • Giant Cell Arteritis
    • Magnetic Resonance Imaging (MRI)
    • Philadelphia, Pennsylvania
      3400 Civic Center Blvd
    May 9, 2023

    Applanation Tonometry in the Diagnosis of Giant Cell Arteritis

    Not yet recruiting
    • Giant Cell Arteritis
    • Applanation tonometry
    • Montreal, Quebec, Canada
      Vasculitis Clinic, Hopital du Sacre-Coeur de Montreal
    Jan 26, 2023

    Giant Cell Arteritis Trial in Nice

    Completed
    • Giant Cell Arteritis
      • Nice, Alpes-Maritimes, France
        Hospital of the Archet
      Jul 20, 2022

      Disorders of Consciousness Through Multimodal Observations

      Recruiting
      • Disorders of Consciousness
      • +3 more
      • Coma scales
      • +2 more
      • Paris, France
      • +3 more
      Mar 12, 2021

      Vasculitis, Diagnoses Disease Trial in Würzburg (CXCR4-PET)

      Recruiting
      • Vasculitis
      • Diagnoses Disease
      • CXCR4-PET
      • Würzburg, Bayern, Germany
        Departement of Internal Medicine II, Rheumatology/Clinical Immun
      Dec 4, 2022

      Giant Cell Arteritis Trial in Brest, Lille, Mulhouse (Tocilizumab)

      Completed
      • Giant Cell Arteritis
      • Brest, France
      • +2 more
      Sep 2, 2020

      Individuals With Giant Cell Arteritis

      Completed
      • Temporal Arteritis
        • Boston, Massachusetts
        • +8 more
        Jul 11, 2022

        Giant Cell Arteritis Trial in Worldwide (Sarilumab SAR153191, Sarilumab matching , Prednisone)

        Terminated
        • Giant Cell Arteritis
        • Sarilumab SAR153191
        • +3 more
        • Boca Raton, Florida
        • +60 more
        Mar 15, 2022

        Giant Cell Arteritis Trial in Worldwide (Guselkumab, Placebo)

        Recruiting
        • Giant Cell Arteritis
        • Kansas City, Kansas
        • +33 more
        Aug 11, 2022

        Study of Circulating Microparticles in Giant Cell Arteritis

        Recruiting
        • Giant Cell Arteritis
        • Acute Phase
        • Blood sample
        • Caen, France
          Centre Hospitalier Universitaire Côte de Nacre
        Mar 8, 2022

        Adrenal Insufficiency, Polymyalgia Rheumatica, Giant Cell Arteritis Trial in Aarhus, Copenhagen, Odense (Hydrocortisone, Placebo

        Recruiting
        • Adrenal Insufficiency
        • +2 more
        • Aarhus, Denmark
        • +2 more
        Jun 23, 2022

        Giant Cell Arteritis Trial in Germany (Secukinumab 300 mg, s.c., Prednisolone, Placebo)

        Completed
        • Giant Cell Arteritis
        • Secukinumab 300 mg, s.c.
        • +2 more
        • Berlin, Germany
        • +10 more
        Feb 25, 2022